1. De novo generation of HSCs from somatic and pluripotent stem cell sources;Vo;Blood J. Am. Soc. Hematol.,2015
2. Curative therapies: allogeneic hematopoietic cell transplantation from matched related donors using myeloablative, reduced intensity, and nonmyeloablative conditioning in sickle cell disease,2018
3. Ex vivo HSC expansion challenges the paradigm of unidirectional human hematopoiesis;Papa;Ann. N. Y. Acad. Sci.,2020
4. Gene therapy for sickle cell disease: an update;Demirci;Cytotherapy,2018
5. Pagliuca S., Prata P.H., Xhaard A., Frieri C., Giannoni L., Del Galy A.S., Brignier A., de Fontbrune F.S., Michonneau D., Dhedin N. Long-term outcomes and risk factor analysis of steroid-refractory graft versus host disease after hematopoietic stem, 2023.